Found 10 matching trials
A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:
PHASE4Numerous studies have shown that pharmacodynamics (PD) response profiles va...
Location
University of Florida
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)
PHASE4In patients with heart attacks, the current standard of care is to restore ...
Location
University of Ottawa Heart Institute
Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
PHASE4This study aims to compare the outcome between genotype guided versus clini...
Location
Department of Medicine, the University of Hong Kong, Queen Mary Hospital, Hospital Authority
The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
PHASE3This is a randomized controlled trial designed to evaluate the role of scre...
Location
University of Pittsburgh Medical Center
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD
NAStroke is an important cause of death, disability, and memory problems in a...
Location
University of Calgary
Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.
PHASE4Rationale: Peripheral arterial disease (PAD) is a common presentation of at...
Location
Gelre Ziekenhuizen
A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk
PHASE2In patients with heart attacks, the treatment of choice is to restore blood...
Location
University of Ottawa Heart Institute
Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
PHASE2The objective of the RAPID STEMI study is to evaluate the feasibility, effi...
Location
University of Ottawa Heart Institute
Pharmacogenetics of Clopidogrel in Acute Coronary Syndromes
NAThe antiplatelet agent clopidogrel is an effective drug for the prevention ...
Location
Ospedale Ramazzini
Investigating a Personalized Approach to Anti-Platelet Therapy
PHASE4RAPID PREVENT aims to identify if a personalized (targeted) anti-platelet s...
Location
University of Ottawa Heart Institute